Abstract
The migration of peripheral polymorphonuclear leucocytes (PMNs) of patients with rheumatoid arthritis has been studied both in vivo and in vitro. A significant reduction in the accumulation of PMNs in skin chambers in patients with rheumatoid arthritis compared to controls was observed but no defect in cell movement was detected when the isolated PMNs from the patients were exposed to activated control plasma. However, when PMNs from the control group were tested against activated plasma from patients with rheumatoid arthritis there was a significant decrease in their chemotactic response. It is proposed that there is a humoral defect in the plasma of the patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clark R. A., Kimball H. R., Decker J. L. Neutrophil chemotaxis in systemic lupus erythematosus. Ann Rheum Dis. 1974 Mar;33(2):167–172. doi: 10.1136/ard.33.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gange R. W., Black M. M., Carrington P., McKerron R. Defective neutrophil migration in sarcoidosis. Lancet. 1977 Aug 20;2(8034):379–381. doi: 10.1016/s0140-6736(77)90306-3. [DOI] [PubMed] [Google Scholar]
- Goetzl E. J. Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus. Ann Rheum Dis. 1976 Dec;35(6):510–515. doi: 10.1136/ard.35.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goetzl E. J. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann N Y Acad Sci. 1975 Jun 13;256:210–221. doi: 10.1111/j.1749-6632.1975.tb36048.x. [DOI] [PubMed] [Google Scholar]
- Hurd E. R., Andreis M., Ziff M. Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol. 1977 Jun;28(3):413–425. [PMC free article] [PubMed] [Google Scholar]
- Maderazo E. G., Ward P. A., Woronick C. L., Kubik J., DeGraff A. C., Jr Leukotactic dystunction in sarcoidosis. Ann Intern Med. 1976 Apr;84(4):414–419. doi: 10.7326/0003-4819-84-4-414. [DOI] [PubMed] [Google Scholar]
- Martin A., Lachmann P. J., Halbwachs L., Hobart M. J. Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry. 1976 Apr;13(4):317–324. doi: 10.1016/0019-2791(76)90341-4. [DOI] [PubMed] [Google Scholar]
- Mowat A. G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Invest. 1971 Dec;50(12):2541–2549. doi: 10.1172/JCI106754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quie P. G., Cates K. L. Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis. Am J Pathol. 1977 Sep;88(3):711–726. [PMC free article] [PubMed] [Google Scholar]
- Roberts-Thomson P. J., Hazleman B. L., Barnett I. G., MacLennan I. C., Mowat A. G. Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis. 1976 Aug;35(4):314–320. doi: 10.1136/ard.35.4.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Segal A. W., Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet. 1976 Jul 31;2(7979):219–221. doi: 10.1016/s0140-6736(76)91024-2. [DOI] [PubMed] [Google Scholar]
- Senn H., Holland J. F., Banerjee T. Kinetic and comparative studies on localized leukocyte mobilization in normal man. J Lab Clin Med. 1969 Nov;74(5):742–756. [PubMed] [Google Scholar]
- Walker J. R., Badcock J. K., Ford-Hutchinson A. W., Smith M. J., Billimoria F. J. Effects of a human plasma fraction on the release of chemotactic factors and anaphylatoxin from complement. J Pharm Pharmacol. 1975 Oct;27(10):747–753. doi: 10.1111/j.2042-7158.1975.tb09394.x. [DOI] [PubMed] [Google Scholar]
- Ward P. A., Johnson K. J., Kreutzer D. L. Regulatory dysfunction in leukotaxis. Am J Pathol. 1977 Sep;88(3):701–710. [PMC free article] [PubMed] [Google Scholar]